Picture: Hemolung Respiratory Help System (Photograph courtesy of ALung Applied sciences, Inc)
A low-flow extracorporeal carbon dioxide elimination (ECCO₂R) respiratory machine helps deal with COVID-19 sufferers with acute respiratory failure.
The Hemolung Respiratory Help System (RAS) from ALung Applied sciences, Inc. (Pittsburgh, PA, USA) is the one ECCO₂R machine at present granted an Emergency Use Authorization (EUA) by the Meals and Drug Administration (FDA) for the remedy of COVID-19. ECCO₂R remedy with the Hemolung RAS permits carbon dioxide to be faraway from the blood independently of the lungs with the purpose of facilitating the avoidance or discount of intubation and invasive mechanical air flow. The primary fully-integrated Respiratory Dialysis system, the Hemolung RAS combines superior know-how with user-centered design to offer easy, efficient, and minimally invasive extracorporeal CO2 elimination (ECCO₂R). Eradicating carbon dioxide and delivering oxygen on to the blood permits the affected person’s lungs to relaxation and heal whereas avoiding intubation and/or facilitating protecting air flow.
“We’re happy to have the ability to help on this battle in opposition to the COVID-19 viral illness by offering the usage of the Hemolung RAS as a device for physicians for use together with IMV, by decreasing or eliminating the potential of additional lung harm attributable to excessive ventilator driving pressures, also known as Ventilator Induced Lung Harm (VILI). We’re treating COVID-19 sufferers in better than 20 hospitals worldwide,” stated Mr. Peter M. DeComo, Chairman and CEO of ALung Applied sciences.
“The Hemolung RAS has enabled us to get better sufferers with COVID pneumonia through the pandemic. In choose sufferers the place there’s a selective situation with hypercarbic respiratory acidosis whereas their oxygen necessities have normalized post-Veno-Venous ECMO cannulation, we’ve utilized Hemolung as a bridge of their restoration. We have now observed that these sufferers are capable of wean off mechanical circulatory assist in a gradual method. Moreover, at a time when there was a scarcity of ECMO circuits, our program has relied on using this know-how in stabilizing sufferers with extreme hypercarbic respiratory acidosis whereas offering lung protecting air flow,” said Dr. Bindu Akkanti, MD, Affiliate Professor of Medication, Divisions of Crucial Care, Pulmonary and Sleep Medication, McGovern Medical College, and Director of Coronary heart and Vascular Crucial Care, Memorial Hermann – Texas Medical Heart.
ALung Technologies, Inc.